KD Logo

Leerink Partners’s latest rating for ARCT stock

Arcturus Therapeutics Holdings Inc’s filing revealed that its Chief Financial Officer SASSINE ANDY unloaded Company’s shares for reported $1.6 million on Jun 12 ’24. In the deal valued at $32.03 per share,50,000 shares were sold. As a result of this transaction, SASSINE ANDY now holds 220,526 shares worth roughly $5.57 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Chivukula Pad sold 114 shares, generating $5,130 in total proceeds. Upon selling the shares at $45.00, the Chief Scientific Officer & COO now owns 447,334 shares.

Before that, Chivukula Pad sold 26,000 shares. Arcturus Therapeutics Holdings Inc shares valued at $1,040,234 were divested by the Chief Scientific Officer & COO at a price of $40.01 per share. As a result of the transaction, Chivukula Pad now holds 447,448 shares, worth roughly $11.3 million.

Leerink Partners initiated its Arcturus Therapeutics Holdings Inc [ARCT] rating to an Outperform in a research note published on August 12, 2024; the price target was $70. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. William Blair began covering ARCT with “an Outperform” recommendation on July 24, 2023. H.C. Wainwright revised its rating on May 11, 2023. It rated ARCT as “a Buy” which previously was an “a Neutral”.

Price Performance Review of ARCT

On Tuesday, Arcturus Therapeutics Holdings Inc [NASDAQ:ARCT] saw its stock jump 8.79% to $25.25. Over the last five days, the stock has gained 16.15%. Arcturus Therapeutics Holdings Inc shares have fallen nearly -19.92% since the year began. Nevertheless, the stocks have fallen -1.17% over the past one year. While a 52-week high of $45.00 was reached on 06/05/24, a 52-week low of $17.52 was recorded on 08/09/24. SMA at 50 days reached $20.98, while 200 days put it at $29.04.

Levels Of Support And Resistance For ARCT Stock

The 24-hour chart illustrates a support level at 23.06, which if violated will result in even more drops to 20.86. On the upside, there is a resistance level at 26.38. A further resistance level may holdings at 27.50. The Relative Strength Index (RSI) on the 14-day chart is 71.55, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.00, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 1.04%. Stochastics %K at 93.72% indicates the stock is a selling.

How much short interest is there in Arcturus Therapeutics Holdings Inc?

A steep rise in short interest was recorded in Arcturus Therapeutics Holdings Inc stocks on 2024-09-13, dropping by -0.23 million shares to a total of 5.23 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 5.46 million shares. There was a decline of -4.4%, which implies that there is a negative sentiment for the stock.

Most Popular